Vamorolone for the treatment of patients with Duchenne muscular dystrophy


28 March 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use of vamorolone in the NHS in England.

For the time being, vamorolone is not recommended for the treatment of patients 4 years and over with Duchenne muscular dystrophy.

Read NICE draft guidance consultation

Michael Wonder

Posted by:

Michael Wonder